The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype BPC 157 Banned: Key Facts on the Latest FDA Decision FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette